Basit öğe kaydını göster

dc.contributor.authorBademci G.
dc.contributor.authorYucel E.
dc.contributor.authorAliefendioglu D.
dc.date.accessioned2020-06-25T15:13:27Z
dc.date.available2020-06-25T15:13:27Z
dc.date.issued2005
dc.identifier.issn13042580
dc.identifier.urihttps://hdl.handle.net/20.500.12587/1801
dc.description.abstractMetabolic disturbances such as anoxia and hypoglycemia may adversely alter the development of the neonatal brain. While rapid and appropriate diagnosis with adequate therapy has a good prognosis; delayed detection and/or inappropriate therapy increases the risk of the development of irreversible brain damage. Magnetic resonance imaging (MRI) studies are essential in neonatal hypoglycemia to define the characteristics and severity of cerebral lesions after hypoglycemia, to decide the efficacy of preferred treatment modality and to predict the neurologic outcome. Although acute and long-term radiologic abnormalities associated with hypoglycemic episodes in children and adults are well documented, the details of the situation for neonatal hypoglycemia are still emerging. In this review, the impact of MRI findings of neonatal hypoglycemia on diagnosis, monitoring of treatment and neurologic outcome was discussed. © 2005 - IOS Press and the authors. All rights reserved.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBrain damageen_US
dc.subjectHypoglycemiaen_US
dc.subjectMagnetic resonance imagingen_US
dc.subjectNewbornen_US
dc.titleCerebral MRI findings in neonatal hypoglycemiaen_US
dc.typereviewen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume3en_US
dc.identifier.issue3en_US
dc.identifier.startpage137en_US
dc.identifier.endpage140en_US
dc.relation.journalJournal of Pediatric Neurologyen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster